Sort
39,280 grants matching “leukemia”
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
$322,288Jing Zhang · University Of Wisconsin-Madison · R01 · FY2012 · CA
Functional crosstalk between the Fanconi Anemia and ATRX/DAXX histone chaperone pathways
$322,282Jeongsik Yong · University Of Minnesota · R01 · FY2022 · GM
Functional crosstalk between the Fanconi Anemia and ATRX/DAXX histone chaperone pathways
$322,282Alexandra Theresia Sobeck · University Of Minnesota · R01 · FY2019 · GM
Functional crosstalk between the Fanconi Anemia and ATRX/DAXX histone chaperone pathways
$322,282Alexandra Theresia Sobeck · University Of Minnesota · R01 · FY2020 · GM
Functional crosstalk between the Fanconi Anemia and ATRX/DAXX histone chaperone pathways
$322,282Alexandra Theresia Sobeck · University Of Minnesota · R01 · FY2021 · GM
Studies of the structural rearrangements associated with the dynamic spliceosome
$322,263Melanie Diane Ohi · Vanderbilt University · R01 · FY2015 · GM
ARSENIC TRIOXIDE TREATMENT OF LYMPHOPROLIFERATIVE DISORD
$322,262Mount Sinai School Of Medicine Of Nyu · R01 · FY2001 · CA
ARSENIC TRIOXIDE TREATMENT OF LYMPHOPROLIFERATIVE DISORD
$322,262Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · CA
ARSENIC TRIOXIDE TREATMENT OF LYMPHOPROLIFERATIVE DISORD
$322,262Mount Sinai School Of Medicine Of Nyu · R01 · FY2002 · CA
Peptide-directed protocells and virus-like particles-new nanoparticle platforms f
$322,235Cheryl L Willman · University Of New Mexico Health Scis Ctr · U01 · FY2014 · CA
Antibody V Gene Expression B Cell Lymphocytic Leukemia
$322,228Thomas J. Kipps · University Of California, San Diego · R37 · FY2011 · CA
Functional Genomic Dissection of Refractory Anemia
$322,202Dana-Farber Cancer Institute · R01 · FY2005 · HL
Improving the disposition of antileukemic asparaginase after drug-induced immunotoxicity
$322,194Christian Antonio Fernandez · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Improving the disposition of antileukemic asparaginase after drug-induced immunotoxicity
$322,194Christian Antonio Fernandez · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Immunobiology of Hybrid Resistance
$322,187Michael Bennett · Ut Southwestern Medical Center · R01 · FY2006 · CA
Dendritic Cell Subsets and Paths of Maturation in GVHD
$322,160Warren D Shlomchik · Yale University · P01 · FY2008 · AI
The function of PLZF in innate T cells
$322,125Derek B. Sant'angelo · Rbhs-Robert Wood Johnson Medical School · R01 · FY2013 · AI
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
$322,104Terzah M Horton · Baylor College Of Medicine · R01 · FY2014 · CA
Identifying population specific variants important in toxicity to breast cancer C
$322,057M Eileen Dolan · University Of Chicago · P50 · FY2008 · CA
Identifying population specific variants important in toxicity to breast cancer C
$322,057M Eileen Dolan · University Of Chicago · P50 · FY2007 · CA
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1)
$322,044Konstantin H. Dragnev · Dartmouth-Hitchcock Clinic · UG1 · FY2019 · CA
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis
$322,040Christopher Joachim Lengner · University Of Pennsylvania · R01 · FY2014 · CA
The role of ETV6 in T-cell acute lymphoblastic leukemia
$322,040Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2014 · CA
Pre-B cell receptor signaling in acute lymphoblastic leukemia
$322,040Markus Mãschen · Children'S Hospital Of Los Angeles · R01 · FY2012 · CA
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
$322,040Markus Mãschen · Children'S Hospital Of Los Angeles · R01 · FY2012 · CA